Results 111 to 120 of about 5,735 (170)

Ginsenoside Rb1 attenuates age-associated cognitive impairment by modulating oxidative stress and the SIRT1/eNOS/NO axis. [PDF]

J Ginseng Res
Zhou B, Wu L, Liu D, Xie X, Zhang X, Liu Y, Hao B, Shi G, Yu S, Zheng Z, Lin L, Wang M, Qian X.   +12 more
europepmc   +1 more source

Ginsenoside Rb1 attenuates erythropoietin-exacerbated vascular calcification in chronic kidney disease through BMP2-dependent Smad1/5/9 inhibition. [PDF]

Cytojournal
Li X, Xu Z, Li Y, Luo Y, Zhou J, Zuo D, Xiong W.   +6 more
europepmc   +1 more source

Ginsenoside Rb1 mitigates diabetes-induced erectile dysfunction in rats by reducing oxidative stress and modulating the PI3K/AKT/eNOS pathway. [PDF]

Asian J Androl
Liu ZH, Chen WB, Li JZ, Wang XS, Liu L, Liu HW, Chen GZ, Pan C, Yuan MZ.   +8 more
europepmc   +1 more source

Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition. [PDF]

Allergy
Choi S, Yoo SA, Ji KY, Jung DH, Lee S, Lee KG, Kim KM, Lee JY, Jung MA, Pyun BJ, Hur J, Choi JY, Rhee CK, Kim WU, Kim T.   +14 more
europepmc   +1 more source

Ginsenoside RB1 Influences Macrophage-DPSC Interactions in Inflammatory Conditions. [PDF]

Int Dent J
Li W, Wang Y, Mu W, Guan Y, Yang Y, Tang Y, Wang M, Piao Y, Hou T, Guan X.   +9 more
europepmc   +1 more source

Ginsenoside Rb1 attenuates neuroflammation via activating Wnt/β-catenin signaling pathway to exert neuroprotective effect on cerebral ischemic-reperfusion injury. [PDF]

Front Aging Neurosci
Liu RJ, Zhao X, Zhu YZ, Fu LL, Ge G, Zhu JD.   +5 more
europepmc   +1 more source

Impact of ginsenoside Rb1 on gut microbiome and associated changes in pharmacokinetics in rats. [PDF]

Sci Rep
Chen Y, Zhang KX, Liu H, Zhu Y, Bu QY, Song SX, Li YC, Zou H, You XY, Zhao GP.   +9 more
europepmc   +1 more source

The Mechanism of Ginsenoside Rb1 and Rg1 in Vascular Reaction

Journal of Health & Medical Informatics, 2012
openaire   +1 more source

Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m⁶A RNA modification in NETs-induced endothelial activation. [PDF]

Front Pharmacol
Yang Z, Xiong M, Tang X, Wang P, Cui J, Chen Y, Zhang T.   +6 more
europepmc   +1 more source

Overcoming acquired immunotherapy resistance in non-small cell lung cancer using ginsenoside Rb1-loaded, peptide-enhanced exosome delivery systems. [PDF]

J Nanobiotechnology
Jin X, Wuyun T, Zhang Y, Wang X, Zhao L.
europepmc   +1 more source